Department of Otorhinolaryngology - Head and Neck Surgery, Turku University Hospital and University of Turku, Kiinamyllynkatu 4-8, 20521, Turku, Finland.
Department of Pathology, University of Turku and Turku University Hospital, Kiinamyllynkatu 4-8, 20521, Turku, Finland.
BMC Cancer. 2019 Jun 25;19(1):624. doi: 10.1186/s12885-019-5816-9.
Nasopharyngeal carcinoma (NPC) is a malignant disease with an enigmatic etiology. NPC associates with Epstein-Barr virus (EBV) and human papillomaviruses (HPVs), while immunological factors also play a role in carcinogenesis. Toll-like receptors (TLRs) are pattern recognition receptors that participate in the immunological defence against pathogens, but their functions are also linked to cancer.
In our whole population-based study, we retrieved 150 Finnish NPC cases and studied their tumour samples for TLR1, TLR2, TLR4, TLR5, TLR7, and TLR9 expressions by immunohistochemistry, and for the presence of EBV and high-risk HPVs with EBV RNA and HPV E6/E7 mRNA in situ hybridizations. In addition, we analyzed the TLR expression patterns according to age, tumour histology, EBV/HPV status, and outcome.
We found that all TLRs studied were highly expressed in NPC. Viral status of the tumours varied, and 62% of them were EBV-positive, 14% HPV-positive, and 24% virus-negative. The tumours with strong TLR2 or TLR5 expression were mostly virus-negative or HPV-positive keratinizing squamous cell carcinomas, and the patients with these tumours were significantly older than those with mild or negative TLR2/TLR5 expression. In Kaplan-Meier analysis, the patients with strong TLR5 expression had worse survival compared to the patients with negative or mild TLR5 expression, but the results were linked to other patient and tumour characteristics. In multivariable-adjusted Cox regression analysis, the patients with positive TLR7 tumour expression had better overall survival than those with no TLR7 expression. The 5-year overall survival rates according to TLR7 expression were 66% (mild), 52% (moderate or strong), and 22% (negative).
TLRs are highly expressed in non-endemic NPC. Intensity of TLR2 and TLR5 expressions correlate with viral status, and TLR7 seems to be an independent prognostic factor of non-endemic NPC.
鼻咽癌(NPC)是一种病因复杂的恶性疾病。NPC 与 Epstein-Barr 病毒(EBV)和人乳头瘤病毒(HPV)有关,而免疫因素也在癌变过程中发挥作用。Toll 样受体(TLR)是一种模式识别受体,参与针对病原体的免疫防御,但它们的功能也与癌症有关。
在我们的全人群研究中,我们检索了 150 例芬兰 NPC 病例,并通过免疫组织化学研究了这些肿瘤样本中 TLR1、TLR2、TLR4、TLR5、TLR7 和 TLR9 的表达情况,并通过 EBV RNA 和 HPV E6/E7 mRNA 原位杂交研究了 EBV 和高危 HPV 的存在情况。此外,我们还根据年龄、肿瘤组织学、EBV/HPV 状态和结果分析了 TLR 表达模式。
我们发现所有研究的 TLR 在 NPC 中均高度表达。肿瘤的病毒状态不同,其中 62%为 EBV 阳性,14%为 HPV 阳性,24%为病毒阴性。表达 TLR2 或 TLR5 较强的肿瘤主要为病毒阴性或 HPV 阳性角化鳞状细胞癌,且这些肿瘤患者明显比表达轻度或阴性 TLR2/TLR5 的患者年龄更大。在 Kaplan-Meier 分析中,表达 TLR5 较强的患者与表达阴性或轻度 TLR5 的患者相比,生存状况较差,但结果与其他患者和肿瘤特征有关。在多变量调整的 Cox 回归分析中,表达 TLR7 阳性的肿瘤患者的总生存率高于无 TLR7 表达的患者。根据 TLR7 表达,5 年总生存率分别为 66%(轻度)、52%(中度或强)和 22%(阴性)。
TLR 在非流行地区 NPC 中高度表达。TLR2 和 TLR5 表达的强度与病毒状态相关,而 TLR7 似乎是非流行地区 NPC 的独立预后因素。